ARROWHEAD PHARMACEUTICALS, INC. Annual Return On Assets in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2024.
  • Arrowhead Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -66.5 %, a 171% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Assets for 2024 was -66.5 %, a 171% decline from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Assets for 2023 was -24.6 %, a 2.89% increase from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Return On Assets for 2022 was -25.3 %, a 21.2% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -66.5 -42 -171% Oct 1, 2023 Sep 30, 2024
2023 -24.6 +0.73 +2.89% Oct 1, 2022 Sep 30, 2023
2022 -25.3 -4.42 -21.2% Oct 1, 2021 Sep 30, 2022
2021 -20.9 -5.67 -37.3% Oct 1, 2020 Sep 30, 2021
2020 -15.2 -35.2 -176% Oct 1, 2019 Sep 30, 2020
2019 20 +69.5 Oct 1, 2018 Sep 30, 2019
2018 -49.5 -21.5 -76.6% Oct 1, 2017 Sep 30, 2018
2017 -28.1 +49.8 +64% Oct 1, 2016 Sep 30, 2017
2016 -77.9 -16.8 -27.5% Oct 1, 2015 Sep 30, 2016
2015 -61.1 -26.3 -75.8% Oct 1, 2014 Sep 30, 2015
2014 -34.8 +82.3 +70.3% Oct 1, 2013 Sep 30, 2014
2013 -117 -6.05 -5.45% Oct 1, 2012 Sep 30, 2013
2012 -111 Oct 1, 2011 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.